Key Highlights
- INJ token rallied approximately 9% to reach $4.40 following significant regulatory news
- Injective Institutional Services has obtained registration with the US SEC as a transfer agent
- This approval enables the maintenance of official securities ownership records directly on blockchain
- The platform has previously collaborated with major institutions including Nomura’s Laser Digital, BlackRock, and Hamilton Lane
- The network has also secured listing on ESMA’s Interim MiCA Register across Europe
The price of Injective experienced an approximate 9% increase to $4.40 following the announcement that Injective Institutional Services, its affiliated entity, has successfully obtained registration with the United States Securities and Exchange Commission as a transfer agent.

Transfer agents serve a crucial function by maintaining authoritative ownership records for securities and facilitating updates to these records. The SEC permits registered transfer agents to utilize distributed ledger technology as their primary master securityholder file. This regulatory framework enables ownership documentation to be stored and managed directly on blockchain networks.
This development represents a significant advancement for the tokenized securities sector. Traditionally, most blockchain platforms record ownership information onchain while the legally binding official record remains in conventional databases. This division often creates reconciliation challenges between blockchain-based transactions and traditional legacy infrastructure.
Injective’s new registration status specifically addresses this operational gap. The platform can now maintain securities documentation on its proprietary blockchain infrastructure, effectively unifying these previously separate systems.
Compliant Framework for Tokenized Securities
The transfer agent registration operates in conjunction with Injective Mint, a comprehensive platform enabling issuers to create and oversee assets with built-in compliance mechanisms at the protocol level. Available functionalities include transfer limitations based on holder criteria and geographic jurisdictions, role-specific administrative controls, address freezing capabilities, and regulated minting and redemption processes.
Injective brings established experience to this domain. The platform has previously facilitated tokenized institutional investment funds, publicly traded equities, private company securities, and corporate receivables. Earlier initiatives have included partnerships with prominent organizations such as Nomura’s Laser Digital, BlackRock, and Hamilton Lane.
European Compliance Expansion
The regulatory approval extends beyond American borders. Injective’s INJ MiCA white paper has been added to ESMA’s Interim MiCA Register following successful completion of the mandatory notification and publication procedures across Europe.
According to the organization, both the US transfer agent approval and the European MiCA compliance initiatives form part of a comprehensive strategy to integrate onchain financial systems with the regulatory structures necessary for widespread institutional acceptance.
This announcement emerged during a particularly dynamic period for cryptocurrency regulation in the United States. President Donald Trump has scheduled meetings with representatives from the SEC, CFTC, and prominent crypto companies including Ripple and Coinbase, while the CLARITY Act encounters implementation delays. Additionally, the SEC published a new regulatory framework addressing crypto investment contracts earlier this week.
With this registration, Injective becomes part of an exclusive group of US-based cryptocurrency organizations that have obtained registered transfer agent status.


